Scarisbrick, J. J., Quaglino, P., Whittaker, S., Bagot, M., Guenova, E., Papadavid, E., Prince, H. M., Sanches, J. A., Miyashiro, D. R., Servitje, O., Querfeld, C., Akilov, O., Arumainathan, A., Bennett, L., Battistella, M., Benstead, K., Berti, E., Beylot-Barry, M., Busschots, A., Cowan, R., Dummer, R., Dunnill, G., Estrach, T., Evison, F., Bashir, A., Geskin, L., Gru, A., Guitart, J., Herrera, M. C., Hodak, E., Horwitz, S., Jonak, C., Klemke, C., Knobler, R., Mckay, P., Marschalkó, M., Massone, C., Matin, R., Mitteldorf, C., Novoa, R., Ortiz-Romero, P., Pimpinelli, N., Pujol, R. M., Ranki, A., Vakeva, L., Rieger, K. E., Stadler, R., Trautinger, F., Latzka, J., Vermeer, M., Wachsmuth, R., Weatherhead, S., Wehkamp, U., Wobser, M., Kim, Y. H. (2025). A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification. Blood. https://doi.org/10.1182/blood.2025029628